Tenofovir Alafenamide Versus Entecavir for the Treatment of Chronic Hepatitis B

PHASE4RecruitingINTERVENTIONAL

Enrollment

140

Participants

Timeline

Start Date

August 19, 2019

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2030

Conditions

Hepatitis BViral Hepatitis

Interventions

DRUG

Tenofovir alafenamide

Tenofovir alafenamide 25mg/tab once daily

DRUG

Entecavir

Entecavir 0.5mg/tab once daily

Trial Locations (1)

RECRUITING

Taichung Veterans General Hospital, Taichung

All Listed Sponsors

lead

Taichung Veterans General Hospital

OTHER